These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 29737445)

  • 1. A molecular dynamics investigation of CDK8/CycC and ligand binding: conformational flexibility and implication in drug discovery.
    Cholko T; Chen W; Tang Z; Chang CA
    J Comput Aided Mol Des; 2018 Jun; 32(6):671-685. PubMed ID: 29737445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. All-atomic molecular dynamic studies of human CDK8: insight into the A-loop, point mutations and binding with its partner CycC.
    Xu W; Amire-Brahimi B; Xie XJ; Huang L; Ji JY
    Comput Biol Chem; 2014 Aug; 51():1-11. PubMed ID: 24754906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highlighting the Major Role of Cyclin C in Cyclin-Dependent Kinase 8 Activity through Molecular Dynamics Simulations.
    Ziada S; Diharce J; Serillon D; Bonnet P; Aci-Sèche S
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structure of CDK8/CycC implicates specificity in the CDK/cyclin family and reveals interaction with a deep pocket binder.
    Schneider EV; Böttcher J; Blaesse M; Neumann L; Huber R; Maskos K
    J Mol Biol; 2011 Sep; 412(2):251-66. PubMed ID: 21806996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of CDK8/CycC Ligands with a New Virtual Screening Tool.
    Chen W; Ren X; Chang CA
    ChemMedChem; 2019 Jan; 14(1):107-118. PubMed ID: 30403831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. All-Atomic Molecular Dynamic Studies of Human and
    Xu W; Xie XJ; Faust AK; Liu M; Li X; Chen F; Naquin AA; Walton AC; Kishbaugh PW; Ji JY
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33053834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-kinetic relationship study of CDK8/CycC specific compounds.
    Schneider EV; Böttcher J; Huber R; Maskos K; Neumann L
    Proc Natl Acad Sci U S A; 2013 May; 110(20):8081-6. PubMed ID: 23630251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enriching Anticancer Drug Pipeline with Potential Inhibitors of Cyclin-Dependent Kinase-8 Identified from Natural Products.
    Zehra ; Hussain A; AlAjmi MF; Ishrat R; Hassan MI
    OMICS; 2024 Sep; 28(9):478-488. PubMed ID: 39149808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oncogenic exon 2 mutations in Mediator subunit MED12 disrupt allosteric activation of cyclin C-CDK8/19.
    Park MJ; Shen H; Spaeth JM; Tolvanen JH; Failor C; Knudtson JF; McLaughlin J; Halder SK; Yang Q; Bulun SE; Al-Hendy A; Schenken RS; Aaltonen LA; Boyer TG
    J Biol Chem; 2018 Mar; 293(13):4870-4882. PubMed ID: 29440396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclin C influences the timing of mitosis in fission yeast.
    Banyai G; Szilagyi Z; Baraznenok V; Khorosjutina O; Gustafsson CM
    Mol Biol Cell; 2017 Jul; 28(13):1738-1744. PubMed ID: 28515143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Mediator CDK8-Cyclin C complex modulates Dpp signaling in Drosophila by stimulating Mad-dependent transcription.
    Li X; Liu M; Ren X; Loncle N; Wang Q; Hemba-Waduge RU; Yu SH; Boube M; Bourbon HG; Ni JQ; Ji JY
    PLoS Genet; 2020 May; 16(5):e1008832. PubMed ID: 32463833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dynamics simulation and free energy calculation studies of kinase inhibitors binding to active and inactive conformations of VEGFR-2.
    Wu X; Wan S; Wang G; Jin H; Li Z; Tian Y; Zhu Z; Zhang J
    J Mol Graph Model; 2015 Mar; 56():103-12. PubMed ID: 25594497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding patterns and structure-activity relationship of CDK8 inhibitors.
    Ma D; Chen X; Shen XB; Sheng LQ; Liu XH
    Bioorg Chem; 2020 Mar; 96():103624. PubMed ID: 32078847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK8-Cyclin C Mediates Nutritional Regulation of Developmental Transitions through the Ecdysone Receptor in Drosophila.
    Xie XJ; Hsu FN; Gao X; Xu W; Ni JQ; Xing Y; Huang L; Hsiao HC; Zheng H; Wang C; Zheng Y; Xiaoli AM; Yang F; Bondos SE; Ji JY
    PLoS Biol; 2015 Jul; 13(7):e1002207. PubMed ID: 26222308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTORC1 Down-Regulates Cyclin-Dependent Kinase 8 (CDK8) and Cyclin C (CycC).
    Feng D; Youn DY; Zhao X; Gao Y; Quinn WJ; Xiaoli AM; Sun Y; Birnbaum MJ; Pessin JE; Yang F
    PLoS One; 2015; 10(6):e0126240. PubMed ID: 26042770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysregulation of CDK8 and Cyclin C in tumorigenesis.
    Xu W; Ji JY
    J Genet Genomics; 2011 Oct; 38(10):439-52. PubMed ID: 22035865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediator kinase module and human tumorigenesis.
    Clark AD; Oldenbroek M; Boyer TG
    Crit Rev Biochem Mol Biol; 2015; 50(5):393-426. PubMed ID: 26182352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel CDK8 inhibitors using multiple crystal structures in docking-based virtual screening.
    Wang T; Yang Z; Zhang Y; Yan W; Wang F; He L; Zhou Y; Chen L
    Eur J Med Chem; 2017 Mar; 129():275-286. PubMed ID: 28231524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metadynamics Simulations Distinguish Short- and Long-Residence-Time Inhibitors of Cyclin-Dependent Kinase 8.
    Callegari D; Lodola A; Pala D; Rivara S; Mor M; Rizzi A; Capelli AM
    J Chem Inf Model; 2017 Feb; 57(2):159-169. PubMed ID: 28080056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors.
    Xi M; Chen T; Wu C; Gao X; Wu Y; Luo X; Du K; Yu L; Cai T; Shen R; Sun H
    Eur J Med Chem; 2019 Feb; 164():77-91. PubMed ID: 30594029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.